Author's posts
California Congresswoman Delivers Fake News In Attack Of Biopharma M&A
Unfortunately, the “blockbuster report” from Congresswoman Porter’s Office is instead a tired screed which does not add to the public’s understanding and appreciation of the biopharmaceutical industry.
Do Americans Really Pay Triple The Price Paid By Foreign Countries For Drugs?
By all means, let’s have a constructive dialogue about drug pricing in the U.S. But, sensational analyses claiming that Americans pay three times the price of brand-name drugs than outside the U.S. only inflame the situation.
Mark Cuban Is Going To Help Big Pharma’s Image
Cuban is taking an important step in helping to realize Kolchinsky’s “Biotech Social Contract” – the deal that drug companies has with society in which innovative life-saving drugs have finite proprietary lifetimes and then evolve into inexpensive gene…
Drug Prices Increase And Biopharma Bashing Returns
David Mitchell of Patients for Affordable Drugs is in the forefront: “Pandemic be damned, drug corporations started 2021 just like every other year – raising prices by as much as they think the…
Don’t Hesitate In Getting A Covid-19 Vaccine
However, if the U.S. is ever going to get control of this virus and enable a return to normalcy, people need to get vaccinated. Based on all of the data to date, there is no reason not to. People should get vaccinated as soon as they are able.
Corporate Scientific Leadership Key To Pfizer’s Covid-19 Vaccine Success
Like most companies, Pfizer has a publicly stated purpose: “Breakthroughs that change lives”. Bourla and the Pfizer board delivered on this – big time.
Are Trials That Deliberately Infect People With The Covid-19 Virus Really Necessary?
One of the major justifications for carrying out this trial is that the results will help us get a vaccine more quickly. That’s not the case.
Overcoming Covid-19 Vaccine Hesitancy
People don’t seem to want to take a Covid-19 vaccine.
Lilly’s Barcitinib For Covid-19 – Too Little, Too Late?
Unless Lilly can show more impressive data for barcitinib combinations, such as in a study of barcitinib/remdesivir vs. dexamethasone/remdesivir, an EUA seems premature.
Pharma Companies Should Not Manufacture Covid-19 Vaccines Prematurely
The biopharma’s mantra should be: “We will issue no vaccine before its time.” The public can only benefit from this position.
